FDA Inspection
Sparsha Pharma Usa IncSparsha Pharma Usa Inc – FDA Inspection, Apr 28, 2017
Record Details
This FDA Inspection record concerns Sparsha Pharma Usa Inc, with an inspection on April 28, 2017, issued by the Center for Devices and Radiological Health, covering devices.
View Company Profile
ID · f436042b-bd2b-4515-bdfb-88644f1f9dee
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1010514
- FDA center
- Medical Devices & Rad Health
- Project area
- Compliance: Devices
- Outcome
- Form 483 issued
FDA Citations
21- 21 CFR 211.100(a)Changes to Procedures Not Reviewed, Approved
- 21 CFR 211.110(b)In-process materials specifications
- 21 CFR 211.160(a)Lab controls established, including changes
- 21 CFR 211.165(e)Test methods
- 21 CFR 211.192Written record of investigation incomplete
- 21 CFR 211.194(a)Complete test data included in records
- 21 CFR 211.22(a)Authority lacking to review records, investigate errors
- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 211.68(b)Computer control of master formula records
- 21 CFR 211.68(b)input/output verification
Showing 10 of 21 citations.
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Sparsha Pharma Usa Inc
2| Date | Classification | Office | Project area |
|---|---|---|---|
| September 3, 2026 | Not classified | Los Angeles District Office | Generic Drug Evaluation |
| September 4, 2025 | VAI | Los Angeles District Office | Drug Quality Assurance |
Other documents for Sparsha Pharma Usa Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.